EFFECTS OF NORADRENALINE AND DOPAMINE INFUSIONS ON ARACHIDONIC-ACID METABOLISM IN MAN

被引:10
作者
KERTTULA, T
KAUKINEN, S
RIUTTA, A
SEPPALA, E
MUCHA, I
VAPAATALO, H
ALANKO, J
机构
[1] TAMPERE UNIV HOSP,DEPT ANAESTHESIOL,SF-33521 TAMPERE,FINLAND
[2] TAMPERE UNIV,SCH MED,SF-33101 TAMPERE,FINLAND
[3] HUNGARIAN ACAD SCI,INST ISOTOPES,H-1525 BUDAPEST,HUNGARY
[4] INST BIOMED,DEPT PHARMACOL & TOXICOL,SF-00014 HELSINKI,FINLAND
基金
芬兰科学院;
关键词
ARACHIDONIC ACID; CATECHOLAMINES; DOPAMINE; LEUKOTRIENES; NORADRENALINE; PROSTACYCLIN; THROMBOXANE;
D O I
10.1016/0049-3848(95)00163-L
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We infused noradrenaline (0.025 mu g/kg/min for 60 min, n=7) and dopamine (3.0. mu g/kg/min for 60 min, n=6) into healthy male volunteers to study the effects of these catecholamines on in vivo thromboxane A(2), prostacyclin and leukotriene E(4) production measured as urinary excretions of 11-dehydro-thromboxane (TX) B-2, 2,3-dinor-6-keto-prostaglandin (PG) F-1 alpha and leukotriene (LT) E(4), respectively. Plasma noradrenaline and dopamine concentrations were 2.9+/-0.3 and 233+/-17 nmol/l at the end of the noradrenaline and dopamine infusions, respectively. Noradrenaline decreased thromboxane production and increased leukotriene production almost twofold. It had hardly any effect on prostacyclin production. Dopamine had no significant effects on any of the variables, however it had a tendency to increase prostacyclin and leukotriene production. The results indicate that noradrenaline is a more important modulator of arachidonic acid metabolism than dopamine in vivo.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 25 条
[1]  
ALANKO J, 1992, EICOSANOIDS, V5, P169
[2]   EFFECTS OF CATECHOLAMINES ON EICOSANOID SYNTHESIS WITH SPECIAL REFERENCE TO PROSTANOID LEUKOTRIENE RATIO [J].
ALANKO, J ;
RIUTTA, A ;
VAPAATALO, H .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (06) :677-688
[3]   CATECHOLAMINES DECREASE LEUKOTRIENE-B4 AND INCREASE THROMBOXANE-B2 SYNTHESIS IN A23187-STIMULATED HUMAN WHOLE-BLOOD [J].
ALANKO, J ;
RIUTTA, A ;
VAPAATALO, H ;
MUCHA, I .
PROSTAGLANDINS, 1991, 42 (03) :279-287
[4]  
CRYER PE, 1980, NEW ENGL J MED, V303, P436
[5]  
HENRIKSSON P, 1986, BRIT HEART J, V55, P543
[6]   EFFECT OF DOPAMINE ON RENAL BLOOD-FLOW, PROSTAGLANDINS, RENIN AND ELECTROLYTE EXCRETION IN NORMAL AND HYPERTENSIVE HUMANS [J].
HORTON, R ;
BUGHI, S ;
JOSTVU, E ;
ANTONIPILLAI, I ;
NADLER, J .
AMERICAN JOURNAL OF HYPERTENSION, 1990, 3 (06) :S108-S111
[7]   POSSIBLE INVOLVEMENT OF DIFFERENT GTP-BINDING PROTEINS IN NORADRENALINE-STIMULATED AND THROMBIN-STIMULATED RELEASE OF ARACHIDONIC-ACID IN RABBIT PLATELETS [J].
KAJIYAMA, Y ;
MURAYAMA, T ;
KITAMURA, Y ;
IMAI, S ;
NOMURA, Y .
BIOCHEMICAL JOURNAL, 1990, 270 (01) :69-75
[8]  
KERTTULA T, 1995, IN PRESS PROSTAGLAND
[9]  
LARSSON PT, 1992, EUR J CLIN PHARMACOL, V42, P413
[10]   NOREPINEPHRINE-INDUCED HUMAN PLATELET ACTIVATION IN-VIVO IS ONLY PARTLY COUNTERACTED BY ASPIRIN [J].
LARSSON, PT ;
WALLEN, NH ;
HJEMDAHL, P .
CIRCULATION, 1994, 89 (05) :1951-1957